| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec107bf3f2a61c27d347266c048c5766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_348bdbc21bc5dda3bd6eb048354af929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f551727a323a249f118216e5c8fe48c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fe2ffac12cb4b804fc7b2e76d5e808f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
| filingDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa7710e76ae268f246fa055ad25d6c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e84ccbc455772b18aa83aa18e3b801d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a58eb326ce8f8923757de9aa3cf3d366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e8359697105447bfc3c959f7d6c9aa |
| publicationDate |
2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8084489-B2 |
| titleOfInvention |
Glucagon receptor antagonists, preparation and therapeutic uses |
| abstract |
The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have glucagon receptor antagonist or inverse agonist activity, as well as methods of using these compounds and intermediates and methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising N compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829519-B2 |
| priorityDate |
2005-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |